Real-time analysis of the binding of fluorescent VEGF 165 a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes

Laura E. Kilpatrick, Rachel Friedman‐Ohana, Diana C. Alcobia, +10

Biochemical Pharmacology

Mice expressing fluorescent PAR ₂ reveal that endocytosis mediates colonic inflammation and pain

Rocco Latorre, Alan Hégron, Chloe J. Peach, +17

Proceedings of the National Academy of Sciences

Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells

Chloe J. Peach, Laura E. Kilpatrick, Rachel Friedman‐Ohana, +5

Cell chemical biology

Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief

Alan Hégron, Chloe J. Peach, Raquel Tonello, +14

Proceedings of the National Academy of Sciences

Complex Formation between VEGFR2 and the β2-Adrenoceptor

Laura E. Kilpatrick, Diana C. Alcobia, Carl W. White, +11

Cell chemical biology

Use of NanoBiT and NanoBRET to monitor fluorescent VEGF‐A binding kinetics to VEGFR2/NRP1 heteromeric complexes in living cells

Chloe J. Peach, Laura E. Kilpatrick, Jeanette Woolard, +1

British Journal of Pharmacology

Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain models

Chloe J. Peach, Raquel Tonello, Elisa Damo, +13

Journal of Clinical Investigation

PAR2 on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle-encapsulated AZ3451

Divya Bhansali, Nguyen Huu Tu, Kenji Inoue, +15

Biomaterials

Comparison of the ligand‐binding properties of fluorescent VEGF‐A isoforms to VEGF receptor 2 in living cells and membrane preparations using NanoBRET

Chloe J. Peach, Laura E. Kilpatrick, Jeanette Woolard, +1

British Journal of Pharmacology

Myosin VI drives arrestin-independent internalization and signaling of GPCRs

Nishaben Patel, Léa Ripoll, Chloe J. Peach, +6

Nature Communications